Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosomes for recurrent implantation failure
IRCT20091012002576N44Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of endothelial progenitor cell-derived exosomes in Recurrent Implantation Failure (RIF), sponsored by Tehran University of Medical Sciences. Started Jul 2024; status: completed.
02
Drugs
endothelial progenitor cell-derived exosomes
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20091012002576N44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N44.